Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001070081-23-000020
Filing Date
2023-04-26
Accepted
2023-04-26 08:22:01
Documents
23

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230606xdef14a.htm   iXBRL DEF 14A 1829684
2 GRAPHIC tmb-20230606xdef14a001.jpg GRAPHIC 14201
3 GRAPHIC tmb-20230606xdef14a002.jpg GRAPHIC 4301
4 GRAPHIC tmb-20230606xdef14a003.jpg GRAPHIC 1695
5 GRAPHIC tmb-20230606xdef14a004.jpg GRAPHIC 58633
6 GRAPHIC tmb-20230606xdef14a007.jpg GRAPHIC 57700
7 GRAPHIC tmb-20230606xdef14a018.jpg GRAPHIC 47765
8 GRAPHIC tmb-20230606xdef14a019.jpg GRAPHIC 45832
9 GRAPHIC tmb-20230606xdef14a020.jpg GRAPHIC 48026
10 GRAPHIC tmb-20230606xdef14a024.jpg GRAPHIC 5660
  Complete submission text file 0001070081-23-000020.txt   3512372

Data Files

Seq Description Document Type Size
11 EX-101.SCH tmb-20230606.xsd EX-101.SCH 6287
12 EX-101.DEF tmb-20230606_def.xml EX-101.DEF 8751
13 EX-101.LAB tmb-20230606_lab.xml EX-101.LAB 18313
14 EX-101.PRE tmb-20230606_pre.xml EX-101.PRE 8290
17 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230606xdef14a_htm.xml XML 327801
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35969 | Film No.: 23846896
SIC: 2834 Pharmaceutical Preparations